According to Innate Pharma 's latest financial reports the company's current earnings (TTM) are -HK$0.49 B. In 2022 the company made an earning of -HK$0.49 B a decrease over its 2021 earnings that were of -HK$0.41 B.The earnings displayed on this page is the company's Pretax Income.